genes

Isolated Genes Are None Of Your Business! – SCOTUS Decides Myriad

On June 13, 2013, the U.S. Supreme Court rendered a decision which ruled against the patenting of isolated DNA sequences in their natural form in the now infamous case involving Myriad Genetics, Inc. and the BRCA1 and BRCA2 genes.  The decision represents a major milestone in the legal treatment of biotechnological inventions, and presents a number of relevant […]

The ‘Myriad’ with the Golden ‘Gene’: Australia Upholds Breast Cancer Gene Patents

The Myriad Genetics gene patenting saga has officially shaped international jurisprudence, with the Federal Court of Australia upholding the patents for BRCA1 and BRCA2. In Cancer Voices Australia v. Myriad Genetics, NSD643/2010, Federal Court of Australia (Sydney), the first Australian case to deal with the issue of gene patents, the Court took a similarly liberal […]